Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1578 of 5804
-
Brain scans reveal Ocrelizumab's impact on MS inflammation
Disease control CompletedUsing magnetic resonance-PET (MR-PET) imaging with \[11C\]PBR28, a second-generation 18kDa translocator protein (TSPO) radiotracer, we have previously demonstrated abnormally high TSPO expression, indicative of microglia activation, across different brain tissue compartments of m…
Phase: PHASE4 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
App-based therapy shows promise in preventing chronic pain after teen spinal surgery
Symptom relief CompletedThis is a randomized controlled trial to test effectiveness of the SurgeryPal intervention vs. education control to improve acute and chronic pain and health outcomes in youth undergoing major musculoskeletal surgery. Youth will be randomized on an individual level using a factor…
Phase: NA • Sponsor: Seattle Children's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Robotic arm training shows promise for stroke patients
Symptom relief OngoingLoss of arm function is a common and distressing consequence of stroke. Neurotechnology-aided rehabilitation could be a promising approach to accelerate the recovery of upper limb functional impairments. This multicentre randomized controlled trial is aimed at assessing the effic…
Phase: NA • Sponsor: IRCCS San Raffaele Roma • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
Experimental drug targets rare thymus cancers after chemotherapy fails
Disease control OngoingBackground: Thymoma and thymic carcinoma are diseases of the thymus. Platinum-based chemotherapy is the standard treatment for these diseases. But in many cases, the disease returns after treatment. Researchers want to see if a new drug can help. Objective: To see if bintrafus…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Leukemia drug holiday: study tests if patients can pause treatment
Disease control OngoingThis is a single-arm, phase II study to evaluate safety and efficacy of tyrosine kinase inhibitor (TKI) cessation for chronic myeloid leukemia (CML) patients with stable molecular response in a real world population.
Phase: PHASE2 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Could this pill help when OCD meds fall short?
Symptom relief CompletedThe study's purpose is to evaluate the efficacy and safety of troriluzole as adjunctive therapy compared to placebo in subjects with Obsessive Compulsive Disorder (OCD)
Phase: PHASE3 • Sponsor: Biohaven Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
New chemo combo shows promise for rare sarcoma
Disease control Recruiting nowSoft tissue sarcoma (STS) is rare malignancy of mesodermal origin, representing less than 1% of all malignant neoplasms. They are a group of diseases encompassing diverse histological subtypes with very different biomorphologies, prognoses, and responses to treatments. At advance…
Phase: PHASE2 • Sponsor: Yonsei University • Aim: Disease control
Last updated Jun 27, 2026 12:27 UTC
-
Can a breathing machine or a drug boost exercise benefits for spinal cord injury?
Disease control OngoingOver the past ten years, the Cardiovascular Research Laboratory at Spaulding has refined a unique form of exercise for those with spinal cord injuries (SCI). Functional Electrical Stimulation Row Training (FESRT) couples volitional arm and electrically controlled leg exercise, re…
Phase: PHASE2 • Sponsor: Spaulding Rehabilitation Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Horse therapy shows promise for autism and mental health
Symptom relief CompletedThis randomized control trial (RCT) seeks to assess the mechanisms underlying Therapeutic Horseback Riding's (THR) previously observed significant positive effects on ASD youth, particularly those with co-occurring psychiatric disorders, and to refine information on the durabilit…
Phase: NA • Sponsor: University of Colorado, Denver • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC
-
Can simple samples predict transplant success? new study aims to unlock clues for Longer-Lasting organs
Knowledge-focused Recruiting nowIncreased indications for transplantation continue to worsen the shortage of organs and need the extension of graft sampling criteria and the search for new potential sources of organs. Despite undeniable success in the short term, due to major advances in surgery, medicine and r…
Phase: NA • Sponsor: University Hospital, Limoges • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Mind-Controlled bionic hand gets closer: Micro-Electrodes implanted in nerves
Disease control Recruiting nowThe investigators will investigate the device feasibility of human peripheral nerves and muscles recording and stimulation using percutaneous Utah Slanted Electrode Arrays (pUSEAs) implanted into residual peripheral arm nerves and EMG electrodes implanted in the residual muscles …
Phase: NA • Sponsor: University of Utah • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Could a palm extract help fight a rare genetic brain disease?
Disease control CompletedCADASIL is a paradigmatic cerebral small vessel disease responsible for white-matter lesions, accumulation of lacunes, microbleeds and cerebral atrophy. The disease is responsible for stroke and cognitive decline associated with motor disability. The number of incident lacunes, a…
Phase: PHASE2 • Sponsor: Hovid Berhad • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New 'See and Treat' combo targets tough pancreatic cancer
Disease control Recruiting nowThis is a Phase I, first-in-human study to evaluate the safety and efficacy of the \[68Ga\]Ga DOTA-5G and \[177Lu\]Lu DOTA-ABM-5G theranostic pair in patients with locally advanced or metastatic pancreatic adenocarcinoma (PDAC).
Phase: EARLY_PHASE1 • Sponsor: University of California, Davis • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New hope for PSC patients: drug targets debilitating itch
Symptom relief OngoingThe purpose of this clinical research study is to learn more about the use of the study medicine, volixibat, for the treatment of pruritus (itching) associated with Primary Sclerosing Cholangitis (PSC), and to assess the possible impact on the disease progression of PSC.
Phase: PHASE2 • Sponsor: Mirum Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC
-
New blood test could spare thousands from unnecessary lung surgery
Diagnosis OngoingThis study evaluates the how addition of the Nodify XL2 test result impacts the clinical management of newly identified solid lung nodules assessed as low to moderate risk of cancer.
Sponsor: Biodesix, Inc. • Aim: Diagnosis
Last updated Jun 26, 2026 18:51 UTC
-
Could morphine finally silence the hacking cough of IPF?
Symptom relief CompletedIdiopathic pulmonary fibrosis (IPF) is a disease of unknown cause that results in scarring of the lungs. Cough is reported by 85% of patients with IPF and can be a distressing symptom with significant physical, social and psychological consequences particularly anxiety and depre…
Phase: PHASE3 • Sponsor: Royal Brompton & Harefield NHS Foundation Trust • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
New device aims to seal brain aneurysms without surgery
Disease control CompletedThe purpose of this Post-Market Clinical Follow-up study is to assess the safety and performance of the Trenza in the treatment of intracranial aneurysms.
Sponsor: Stryker Neurovascular • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New hope for advanced kidney cancer: experimental combo therapies under study
Disease control OngoingSubstudy 03B is part of a larger research study that is testing experimental treatments for renal cell carcinoma (RCC). The larger study is the umbrella study (U03). The goal of substudy 03B is to evaluate the safety and efficacy of experimental combinations of investigational a…
Phase: PHASE1, PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Can a common supplement slow lung scarring? new trial targets gene clue
Disease control CompletedThe purpose of this study is to compare the effect of n-acetylcysteine (NAC) plus standard care with matched placebo plus standard of care in patients diagnosed with idiopathic pulmonary fibrosis (IPF) who have the TOLLIP rs3750920 TT genotype. The study will compare the time to …
Phase: PHASE3 • Sponsor: Fernando J Martinez • Aim: Disease control
Last updated Jun 27, 2026 11:04 UTC
-
Jail telehealth program aims to keep women off opioids after release
Disease control CompletedThis trial will test the effectiveness of delivering medication for opioid use disorder (MOUD) pre-treatment via telehealth, alone and with peer navigation, to increase MOUD initiation and maintenance in the community following jail release. This trial will focus on incarcerated …
Phase: NA • Sponsor: Michele Staton • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC